Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Neuromyelitis optica (NMO)
NMO spectrum disorders
Idiopathic inflammatory demyelinating disorder of CNS characterized by severe attacks of optic neuritis and myelitis
Hyperintense, mildly enlarged optic nerves
Expansile, hyperintense cord signal, ≥ 3 segments
Long segment optic nerve enhancement
Acute cord lesions show patchy enhancement
Patchy enhancement with blurred margins (“cloud-like” enhancement) in cerebral lesions
“Pencil-thin” ependymal enhancement
Multiple sclerosis
Radially oriented, well-demarcated perivenular lesions
Patchy cord lesions > > long multisegmental
Optic neuritis
Transverse myelitis
Syringomyelia
Spinal cord neoplasm
Serum marker: NMO-IgG , targets water channel aquaporin-4 (AQP4)
Seen in 70% of NMO patients, 99% specificity
Hallmark = severe optic neuropathy, myelopathy
May progress to blindness
20% present with brainstem symptoms at disease onset
Relapsing course in 90% of patients
Anti-AQP4 antibody positivity as prognostic marker
Acute exacerbation: IV corticosteroids, immunosuppressives
Neuromyelitis optica (NMO)
Neuromyelitis optica spectrum disorders (NMOSD)
Devic syndrome
Idiopathic inflammatory demyelinating disorder of CNS characterized by severe attacks of optic neuritis and myelitis
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here